Epidemiological analysis of nifedipine and phenytoin-induced gingival overgrowth in users of the Primary Health Care System

PURPOSES: The aim of this study was to evaluate the prevalence of drug-induced gingival overgrowth (DIGO) in Brazilian users of nifedipine and/or phenytoin and to determine the presence of predisposing/modifying factors. METHODS: Demographic, pharmacological, and periodontal data were obtained from 100 users of the Brazilian Primary Health Care System in Diamantina, Jequitinhonha Valley, Minas Gerais state, Brazil, who were taking nifedipine and/or phenytoin. Clinical evaluations including gingival overgrowth analysis were carried out by a single calibrated examiner. Bivariate analysis (Chi-square test or Student's t-test) were used to identify demographic, periodontal and drug-related significant factors associated with gingival overgrowth severity. Multivariate analysis (Poisson regression) was used to assess confounding factors. RESULTS: The prevalence of DIGO was high (86%), but its severity was predominately mild. The prevalence of DIGO was significantly higher in phenytoin users than in nifedipine users (p=0.01). There was no association between DIGO and demographic, pharmacological or periodontal variables. CONCLUSION: The high occurrence of DIGO among users of nifedipine and phenytoin emphasizes the importance of the dentist as part of the public health team to provide the prevention, early diagnostic, and control of this alteration.

Saved in:
Bibliographic Details
Main Authors: Fonseca,Luciara Viana Leão, Martelli Júnior,Hercílio, Gonçalves,Patrícia Furtado, Carvalho,Fillipe Mateus Castro de, Coletta,Ricardo Della, Bonan,Paulo Rogério Ferreti
Format: Digital revista
Language:English
Published: Pontifícia Universidade Católica do Rio Grande do Sul 2010
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1980-65232010000200007
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1980-65232010000200007
record_format ojs
spelling oai:scielo:S1980-652320100002000072011-08-26Epidemiological analysis of nifedipine and phenytoin-induced gingival overgrowth in users of the Primary Health Care SystemFonseca,Luciara Viana LeãoMartelli Júnior,HercílioGonçalves,Patrícia FurtadoCarvalho,Fillipe Mateus Castro deColetta,Ricardo DellaBonan,Paulo Rogério Ferreti Nifedipine phenytoin gingival overgrowth primary health care PURPOSES: The aim of this study was to evaluate the prevalence of drug-induced gingival overgrowth (DIGO) in Brazilian users of nifedipine and/or phenytoin and to determine the presence of predisposing/modifying factors. METHODS: Demographic, pharmacological, and periodontal data were obtained from 100 users of the Brazilian Primary Health Care System in Diamantina, Jequitinhonha Valley, Minas Gerais state, Brazil, who were taking nifedipine and/or phenytoin. Clinical evaluations including gingival overgrowth analysis were carried out by a single calibrated examiner. Bivariate analysis (Chi-square test or Student's t-test) were used to identify demographic, periodontal and drug-related significant factors associated with gingival overgrowth severity. Multivariate analysis (Poisson regression) was used to assess confounding factors. RESULTS: The prevalence of DIGO was high (86%), but its severity was predominately mild. The prevalence of DIGO was significantly higher in phenytoin users than in nifedipine users (p=0.01). There was no association between DIGO and demographic, pharmacological or periodontal variables. CONCLUSION: The high occurrence of DIGO among users of nifedipine and phenytoin emphasizes the importance of the dentist as part of the public health team to provide the prevention, early diagnostic, and control of this alteration.info:eu-repo/semantics/openAccessPontifícia Universidade Católica do Rio Grande do SulRevista Odonto Ciência v.25 n.2 20102010-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1980-65232010000200007en10.1590/S1980-65232010000200007
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Fonseca,Luciara Viana Leão
Martelli Júnior,Hercílio
Gonçalves,Patrícia Furtado
Carvalho,Fillipe Mateus Castro de
Coletta,Ricardo Della
Bonan,Paulo Rogério Ferreti
spellingShingle Fonseca,Luciara Viana Leão
Martelli Júnior,Hercílio
Gonçalves,Patrícia Furtado
Carvalho,Fillipe Mateus Castro de
Coletta,Ricardo Della
Bonan,Paulo Rogério Ferreti
Epidemiological analysis of nifedipine and phenytoin-induced gingival overgrowth in users of the Primary Health Care System
author_facet Fonseca,Luciara Viana Leão
Martelli Júnior,Hercílio
Gonçalves,Patrícia Furtado
Carvalho,Fillipe Mateus Castro de
Coletta,Ricardo Della
Bonan,Paulo Rogério Ferreti
author_sort Fonseca,Luciara Viana Leão
title Epidemiological analysis of nifedipine and phenytoin-induced gingival overgrowth in users of the Primary Health Care System
title_short Epidemiological analysis of nifedipine and phenytoin-induced gingival overgrowth in users of the Primary Health Care System
title_full Epidemiological analysis of nifedipine and phenytoin-induced gingival overgrowth in users of the Primary Health Care System
title_fullStr Epidemiological analysis of nifedipine and phenytoin-induced gingival overgrowth in users of the Primary Health Care System
title_full_unstemmed Epidemiological analysis of nifedipine and phenytoin-induced gingival overgrowth in users of the Primary Health Care System
title_sort epidemiological analysis of nifedipine and phenytoin-induced gingival overgrowth in users of the primary health care system
description PURPOSES: The aim of this study was to evaluate the prevalence of drug-induced gingival overgrowth (DIGO) in Brazilian users of nifedipine and/or phenytoin and to determine the presence of predisposing/modifying factors. METHODS: Demographic, pharmacological, and periodontal data were obtained from 100 users of the Brazilian Primary Health Care System in Diamantina, Jequitinhonha Valley, Minas Gerais state, Brazil, who were taking nifedipine and/or phenytoin. Clinical evaluations including gingival overgrowth analysis were carried out by a single calibrated examiner. Bivariate analysis (Chi-square test or Student's t-test) were used to identify demographic, periodontal and drug-related significant factors associated with gingival overgrowth severity. Multivariate analysis (Poisson regression) was used to assess confounding factors. RESULTS: The prevalence of DIGO was high (86%), but its severity was predominately mild. The prevalence of DIGO was significantly higher in phenytoin users than in nifedipine users (p=0.01). There was no association between DIGO and demographic, pharmacological or periodontal variables. CONCLUSION: The high occurrence of DIGO among users of nifedipine and phenytoin emphasizes the importance of the dentist as part of the public health team to provide the prevention, early diagnostic, and control of this alteration.
publisher Pontifícia Universidade Católica do Rio Grande do Sul
publishDate 2010
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1980-65232010000200007
work_keys_str_mv AT fonsecaluciaravianaleao epidemiologicalanalysisofnifedipineandphenytoininducedgingivalovergrowthinusersoftheprimaryhealthcaresystem
AT martellijuniorhercilio epidemiologicalanalysisofnifedipineandphenytoininducedgingivalovergrowthinusersoftheprimaryhealthcaresystem
AT goncalvespatriciafurtado epidemiologicalanalysisofnifedipineandphenytoininducedgingivalovergrowthinusersoftheprimaryhealthcaresystem
AT carvalhofillipemateuscastrode epidemiologicalanalysisofnifedipineandphenytoininducedgingivalovergrowthinusersoftheprimaryhealthcaresystem
AT colettaricardodella epidemiologicalanalysisofnifedipineandphenytoininducedgingivalovergrowthinusersoftheprimaryhealthcaresystem
AT bonanpaulorogerioferreti epidemiologicalanalysisofnifedipineandphenytoininducedgingivalovergrowthinusersoftheprimaryhealthcaresystem
_version_ 1756434550809952256